Affichage 1 à 8 des 8 essais cliniques
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Coordonnateur(rice) | ||
---|---|---|---|
(EN) A Phase 2/3 Multicenter, Open-label, 3-arm, 2-Stage Randomized Study of ASP2215 (Gilteritinib), Combination of ASP2215 Plus Azacitidine and Azacitidine Alone in the Treatment of Newly Diagnosed Acute Myeloid Leukemia With FLT3 Mutation in Patients Not Eligible for Intensive Induction Chemotherapy
2215-CL-0201 NCT02752035 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Leucémie myéloïde aiguë (LMA) |
Lorena Iglesias 514-934-1934 poste 34907 |
(EN) An Open-label, Multicenter, Phase 1b Study of JNJ-74494550 (Cusatuzumab; Anti-CD70 Monoclonal Antibody) in Combination With Background Therapy for the Treatment of Subjects With Acute Myeloid Leukemia
ELEVATE NCT04150887 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Leucémie myéloïde aiguë (LMA) |
Henry Nchienzia 514-934-1934 |
Banque des cellules leucémique du Québec
banque cellules leucémique ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Linda Vallée 418-649-0252 poste 66602 |
(EN) A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/ITD AML
2215-CL-0304 NCT02997202 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Leucémie myéloïde aiguë (LMA) |
Manuel Rocha 514-934-1934 poste 35391 |
(EN) A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) With ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD)
CTTC 1901 NCT04202835 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Marie-Claude Lépine 418-649-0252 poste 63401 |
(EN) A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
PEVENAZA NCT04266795 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Marie-Claude Lépine 418-649-0252 poste 63401 |
Banque des cellules leucémique du Québec
banque cellules leucémique ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Marie-Pierre Brochu 418-525-4444 poste 15768 |
(EN) A Phase II Multi-center, Single Arm, Safety and Efficacy Study of Sabatolimab in Combination With Azacitidine and Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) in Adult Patients Unfit for Chemotherapy
STIMULUS-AML1 NCT04150029 ![]() |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Erika Thibault 514-340-8222 |